
248-Reprogramming neuroblastoma by Diet Polyamine Depletion
The paper details research on treating highly lethal childhood cancer neuroblastoma. The study investigates combining the existing drug difluoromethylornithine (DFMO), which inhibits polyamine synthesis, with a proline- and arginine-free diet to enhance therapeutic outcomes. Researchers found that this combined approach drastically depleted the polyamine precursor ornithine, leading to a significant survival benefit and tumor differentiation in mouse models. Mechanistically, this depletion causes specific ribosome stalling at codons ending in adenosine, preferentially suppressing the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.